Advanced Or Metastatic Adrenocortical Carcinoma clinical trials

Explore recruiting advanced or metastatic adrenocortical carcinoma clinical trials.

Recruiting advanced or metastatic adrenocortical carcinoma studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Advanced Or Metastatic Adrenocortical Carcinoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

First-in-Human trial of DS9051b in participants with advanced solid tumors

France

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Advanced Or Metastatic Adrenocortical Carcinoma trials by city

Advanced Or Metastatic Adrenocortical Carcinoma clinical trials

Recruiting advanced or metastatic adrenocortical carcinoma studies right now

Cabozantinib in Combination With Pembrolizumab for the Treatment of Patients With Locally Advanced, Metastatic, or Unresectable Adrenal Cortical Cancer

Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI

A Study of DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate Cancer

Also recruiting in Europe

First-in-Human trial of DS9051b in participants with advanced solid tumors

Advanced Or Metastatic Adrenocortical Carcinoma trials by city

Other conditions